← Leaderboards
Fuzhong Zhang
Washington University
$3,361,097
Attributed
$4,505,408
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,505,408 · 2
By mechanism
R01$2,288,622 · 1
R35$2,216,786 · 1
Top collaborators
- Jianjun Guan4 shared
Most similar at Washington University
Same institution · by research overlap
- Jianjun Guan$11,127,603
- Petra A Levin$7,709,900
- Mohamed A. Zayed$7,854,663
- Eduardo A. Groisman$21,000,681
- Jennifer G Duncan$574,835
Others in their field
Other Emerging Leaders on “Environment”
- Valerie Koch · University Corporation For Atmospheric Res$244,517,972
- Scott Topper · Broad Institute, Inc.$77,958,806
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$66,503,514
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Prasant Mohapatra · University Of California At Davis$40,097,014
Research focus
EnvironmentEffective TherapyProteinsAntibiotic ToleranceTranscriptional RegulationEtiologyRegulationHeterogeneityMetabolicRecurrent DiseaseDrug ToleranceGrowthBacteriaMetabolic ControlAffectLifeShapesCellsCell GrowthGeneticFatty AcidsAllosteric RegulationData AnalysesFrequencies
Grant awards (10)
Targeted delivery of a proangiogenic and promyogenic protein for regeneration of diabetic ischemic limbs$580,598
R01 · FY2025 · HL
Targeted delivery of a proangiogenic and promyogenic protein for regeneration of diabetic ischemic limbs$568,987
R01 · FY2024 · HL
Targeted delivery of a proangiogenic and promyogenic protein for regeneration of diabetic ischemic limbs$582,468
R01 · FY2023 · HL
None-genetic metabolic heterogeneity and its influence on drug tolerance$393,750
R35 · FY2023 · GM · contact PI
Supplement for Purchase of a Cell Sorter for R35GM133797$249,286
R35 · FY2023 · GM · contact PI
Targeted delivery of a proangiogenic and promyogenic protein for regeneration of diabetic ischemic limbs$556,569
R01 · FY2022 · HL
None-genetic metabolic heterogeneity and its influence on drug tolerance$393,750
R35 · FY2022 · GM · contact PI
None-genetic metabolic heterogeneity and its influence on drug tolerance$393,750
R35 · FY2021 · GM · contact PI
None-genetic metabolic heterogeneity and its influence on drug tolerance$393,750
R35 · FY2020 · GM · contact PI
None-genetic metabolic heterogeneity and its influence on drug tolerance$392,500
R35 · FY2019 · GM · contact PI